Search Results - I. L. Davydkin

Refine Results
  1. 1
    Marfanoid appearance as a risk factor for atrial fibrillation in patients with osteoporosis

    Marfanoid appearance as a risk factor for atrial fibrillation in patients with osteoporosis by I. A. Zolotovskaya, I. L. Davydkin

    Published 2016-06-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatment

    Evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatment by A. V. Chibashova, I. L. Davydkin

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    THE OPPORTUNITIES FOR RISK REDUCTION OF RECURRENT STROKE IN ATRIAL FIBRILLATION

    THE OPPORTUNITIES FOR RISK REDUCTION OF RECURRENT STROKE IN ATRIAL FIBRILLATION by I. L. Davydkin, I. A. Zolotovskaya

    Published 2015-06-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Atherosclerosis of the carotid arteries: clinical significance (a literature review)

    Atherosclerosis of the carotid arteries: clinical significance (a literature review) by M. A. Fedorina, I. L. Davydkin, O. A. Germanova

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    The Role of Rivaroxaban in a Comprehensive Protection Strategy for Patients with Atrial Fibrillation

    The Role of Rivaroxaban in a Comprehensive Protection Strategy for Patients with Atrial Fibrillation by I. A. Zolotovskaya, V. D. Sabanova, I. L. Davydkin

    Published 2021-05-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Omega-3 polyunsaturated fatty acids in the prevention of postoperative atrial fibrillation in open heart surgery: a systematic review and meta-analysis

    Omega-3 polyunsaturated fatty acids in the prevention of postoperative atrial fibrillation in open heart surgery: a systematic review and meta-analysis by O. A. Rubanenko, A. O. Rubanenko, I. L. Davydkin

    Published 2023-03-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Stress test with physical activity: features of hemodynamics and kinetics of carotid arteries in atherosclerotic stenosis

    Stress test with physical activity: features of hemodynamics and kinetics of carotid arteries in atherosclerotic stenosis by M. A. Fedorina, I. L. Davydkin, O. A. Germanova

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    NEWLY DIAGNOSED STROKE-ASSOCIATED ATRIAL FIBRILLATION: RISK OF DEVELOPMENT OF UNFAVORABLE CLINICAL OUTCOMES (THE RESULTS OF THE SUBANALYSIS COHORT STUDY APOLLO)

    NEWLY DIAGNOSED STROKE-ASSOCIATED ATRIAL FIBRILLATION: RISK OF DEVELOPMENT OF UNFAVORABLE CLINICAL OUTCOMES (THE RESULTS OF THE SUBANALYSIS COHORT STUDY APOLLO) by I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov

    Published 2017-09-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS AFTER CARDIOEMBOLIC STROKE: EVALUATION OF TREATMENT ADHERENCE IN REAL PRACTICE (Cohort study “APOLLON”)

    ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS AFTER CARDIOEMBOLIC STROKE: EVALUATION OF TREATMENT ADHERENCE IN REAL PRACTICE (Cohort study “APOLLON”) by I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov

    Published 2017-08-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    CLINICAL SIGNS OF CHEMOTHERAPY-INDUCED NEUROPATHY IN CANCER PATIENTS AND PHARMACOTHERAPY CORRECTION OPTIONS

    CLINICAL SIGNS OF CHEMOTHERAPY-INDUCED NEUROPATHY IN CANCER PATIENTS AND PHARMACOTHERAPY CORRECTION OPTIONS by I. A. Zolotovskayaia, I. L. Davydkin, T. M. Lokshtanova, A. E. Orlov

    Published 2018-03-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)

    Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL) by I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov, V. A. Kokorin

    Published 2019-05-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    FUNCTIONAL STATE OF THE MICROCIRCULATION OF THE SKIN ACCORDING TO LASER DOPPLER FLOWMETRY IN PATIENTS WITH ATRIAL FIBRILLATION WHO UNDERWENT CARDIOEMBOLIC STROKE

    FUNCTIONAL STATE OF THE MICROCIRCULATION OF THE SKIN ACCORDING TO LASER DOPPLER FLOWMETRY IN PATIENTS WITH ATRIAL FIBRILLATION WHO UNDERWENT CARDIOEMBOLIC STROKE by I. A. Zolotovskaya, I. L. Davydkin, A. A. Fedorovich, O. M. Drapkina

    Published 2017-12-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Gene and genotype frequencies of immunoglobulin-like natural killer cell receptors in the population of Samara region

    Gene and genotype frequencies of immunoglobulin-like natural killer cell receptors in the population of Samara region by D. Yu. Klyuchnikov, Yu. Yu. Teterina, O. V. Tyumina, I. L. Davydkin

    Published 2023-12-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Role of homocysteine metabolism in the development of endothelial dysfunction and hypertension in patients with multiple myeloma

    Role of homocysteine metabolism in the development of endothelial dysfunction and hypertension in patients with multiple myeloma by I. L. Davydkin, E. V. Mordvinova, T. P. Kuzmina, K. V. Naumova, E. S. Fatenkova

    Published 2022-02-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Assessment of Clinical and Diagnostic Indicators of Cardiovascular Toxicity in Patients with Non-Hodgkin’s Lymphomas in the Course of Programmatic Antitumor Therapy

    Assessment of Clinical and Diagnostic Indicators of Cardiovascular Toxicity in Patients with Non-Hodgkin’s Lymphomas in the Course of Programmatic Antitumor Therapy by G. R. Gimatdinova, O. E. Danilova, I. L. Davydkin, O. A. Rubanenko, T. Y. Stepanova

    Published 2024-04-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Diagnostic capabilities of instrumental methods for studying early cardiovascular adverse events in patients with lymphoproliferative disorders, quality and safety issues

    Diagnostic capabilities of instrumental methods for studying early cardiovascular adverse events in patients with lymphoproliferative disorders, quality and safety issues by G. R. Gimatdinova, O. E. Danilova, I. L. Davydkin, U. L. Dzhulakyan, E. V. Usenko

    Published 2024-03-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Genetic polymorphisms associated with the development of arrhythmic type of cardiovascular events

    Genetic polymorphisms associated with the development of arrhythmic type of cardiovascular events by G. R. Gimatdinova, O. E. Danilova, I. L. Davydkin, R. K. Khairetdinov, A. V. Antipova

    Published 2022-09-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Features of the leukocyte pool of umbilical cell blood cell concentrate prepared for long-term cryostorage

    Features of the leukocyte pool of umbilical cell blood cell concentrate prepared for long-term cryostorage by O. V. Tyumina, P. A. Ovchinnikov, L. M. Trusova, I. V. Tyumin, I. L. Davydkin

    Published 2024-04-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Metabolic profile of blast cells in acute myeloid leukemia. Literature review

    Metabolic profile of blast cells in acute myeloid leukemia. Literature review by A. V. Khaliulin, I. I. Zanin, A. V. Lyamin, I. L. Davydkin, I. A. Selezneva

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Change of concentration of biochemical markers of dysfunction of endothelium at intake of inhibitors of tyrosinekinase of I and II generations at patients with a chronic myeloid leukemia as risk factor of development of cardiovascular complications

    Change of concentration of biochemical markers of dysfunction of endothelium at intake of inhibitors of tyrosinekinase of I and II generations at patients with a chronic myeloid le... by K. V. Naumova, I. L. Davydkin, E. G. Lomaia, T. Yu. Stepanova, T. P. Kuzmina, D. B. Zammoyeva

    Published 2021-01-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: